Nurix Therapeutics, Inc. (NRIX) vs Novavax, Inc. (NVAX)

• Nurix Therapeutics, Inc. NRIX 15.30 ▲ +3.10%
• Novavax, Inc. NVAX 10.78 ▲ +10.22%

Nurix Therapeutics, Inc. and Novavax, Inc. are both Biotechnology companies. Nurix Therapeutics, Inc. and Novavax, Inc. are of similar size ($1.6B and $1.6B). Novavax, Inc. has negative trailing earnings, so its P/E is not meaningful; Nurix Therapeutics, Inc. trades at 6.1×. Nurix Therapeutics, Inc. grew revenue faster over the last twelve months: 738.8% against −61.3%. Nurix Therapeutics, Inc. has the higher net margin (42.0% vs −18.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Nurix Therapeutics, Inc. leads on 13 and Novavax, Inc. on 2.